▼ PLUNGE

ProPhase Labs Inc.

-32.0%
PRPHNASDAQHealthcare2026-04-16
0.102
收盘价
0.15
前收盘价
-32.00%
涨幅
0.9x
量比

暴跌原因

没有相关新闻。

相关新闻

Pfizer’s New Phase 1 PF-07328948 Study Signals Ongoing Pipeline Investment
Tipranks2026-04-07
Cancer immunotherapy company Purple Biotech keeps its Nasdaq listing
Stocktitan2026-03-17
IPH Ltd. Issues Daily Update on On-Market Share Buy-Back Activity
Tipranks2026-04-12
Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study
Sa.Marketscreener2026-04-13
Pfizer Targets Advanced Kidney Cancer With New PF-08634404 Trial: What Investors Should Know
Tipranks2026-04-07

技术分析

没有技术分析数据。

查看股票详情返回暴涨股列表
ProPhase Labs Inc. +-32.0% 暴涨分析 (2026-04-16) | Alpha Lenz